Get all latest & breaking news on Company Results. Watch videos, top stories and articles on Company Results at moneycontrol.com.

Turning long-form podcasts and interviews into short-form social media clips has become a lucrative career for some. But others say it is a race to the bottom.

Reactivate now to get the information you were looking for! You will get digital access to reviews and ratings for over 8,500 products and services to help you make better choices for life’s big ...

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn. You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing ...

The owner of a bulk cement carrier has been charged with environmental offences following a 2022 crash that sank two tugboats in north-west Tasmania. An Australian Transport Safety Bureau report said ...

Add Yahoo as a preferred source to see more of our stories on Google. Dive into the exhilarating world of the BMW M4 CSL, blending racetrack engineering with sheer driving pleasure. Rolex's new ...

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst ...

A new info-stealing malware called Torg Grabber is stealing sensitive data from 850 browser extensions, more than 700 of them for cryptocurrency wallets. Initial access is obtained through the ...

After teasing a plasma-based manufacturing expansion in the U.S. late last year, CSL is putting in the work and firming up details behind the $1.5 billion project. Monday, the Australian biopharma ...

BRADLEY, Ill. -- Australian biopharmaceutical company CSL announced Monday a major expansion at its Kankakee manufacturing facility, a move that will bring end-to-end plasma processing into the U.S.

Illinois Gov. JB Pritzker on Monday announced a $1.5 billion investment from biotherapeutics company CSL for a new plasma therapy manufacturing plant in Kanakee. CSL will expand its current footprint ...

CSL granted Eli Lilly certain rights for clazakizumab CSl to receive upfront payment of $100 million CSL shares up 2.1% CSL will retain exclusive rights to develop and commercialise clazakizumab for ...